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Background
Two of the existing broadly neutralizing antibodies
(NAbs) to HIV-1 Env, 2F5 and 4E10, recognize conserved
continuous epitopes in the gp41 membrane-proximal
external region. Re-elicitation of NAbs to the 2F5 epitope
by immunization with peptides or chimeric proteins has
so far proven difficult. To improve the efficiency of elicit-
ing 2F5 epitope-directed NAbs, computationally designed
scaffold proteins were used for more optimal presentation
of the crystallographically defined 2F5 epitope (2F5E) to
B cells. Here, we characterize 2F5E-specific B cell subsets
and serum responses elicited by homologous and heterol-
ogous scaffold immunizations, with the overall goal to
understand the rules of immuno-focusing in this novel
system.
Methods
Computationally designed proteins, consisting of non-
HIV proteins engrafted with the structurally defined 2F5E,
were used in sequential immunizations to immuno-focus
the humoral response on the 2F5E graft. A 2F5E-specific B
cell ELISpot assay was developed and used for quantifica-
tion of 2F5E-specific B cells in immunized mice. 2F5E-
specific Ab levels in sera were analyzed by selected ELISA
formats.
Results
A 2F5E-specific B cell ELISpot assay was optimized using
a mouse hybridoma cell line specific for this epitope.
Using this assay, we enumerated the number of 2F5E-spe-
cific antibody-secreting cells and memory B cells induced
by homologous and heterologous scaffold immunization.
Increases in the number of B cells specific for the 2F5
epitope were observed in groups of mice inoculated with
heterologous scaffolds suggesting that the immuno-focus-
ing strategy was successful. Increased Ab responses against
the 2F5E were confirmed by ELISA.
Conclusion
By establishing a highly sensitive 2F5E-specific B cell ELIS-
pot assay, we could quantify 2F5E specific B cell responses
in mice immunized with different scaffold proteins pre-
senting the 2F5E. Further analysis of the quality of the
antibodies induced by homologous and heterologous
scaffold immunizations is ongoing.
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